Glucose Dependent Insulinotropic Receptor Market Report

Global and Region Glucose Dependent Insulinotropic Receptor Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：232
  • REPORT CODE：GMM1019779
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Glucose Dependent Insulinotropic Receptor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Glucose Dependent Insulinotropic Receptormarket, defines the market attractiveness level of Glucose Dependent Insulinotropic Receptor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Glucose Dependent Insulinotropic Receptor industry, describes the types of Glucose Dependent Insulinotropic Receptor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Glucose Dependent Insulinotropic Receptor market and the development prospects and opportunities of Glucose Dependent Insulinotropic Receptor industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Glucose Dependent Insulinotropic Receptor market in Chapter 13.

    By Player:

    • Dong-A Socio Holdings Co Ltd

    • Novartis AG

    • Amgen Inc

    • Hyundai Pharmaceutical Co Ltd

    • CymaBay Therapeutics Inc

    • Takeda Pharmaceutical Co Ltd

    • GlaxoSmithKline Plc

    • F Hoffmann-La Roche Ltd

    • Merck & Co Inc

    • Kowa Co Ltd

    • Yuhan Corp

    • Arena Pharmaceuticals Inc

    • Taisho Pharmaceutical Holdings Co Ltd

    By Type:

    • DA-1241

    • GSK-2041706

    • HD-0471042

    • HD-0471953

    • HOB-047

    • MBX-2982

    • Others

    By End-User:

    • Diabetes

    • Obesity

    • Chronic Obstructive Pulmonary Disease (COPD)

    • Dyslipidemia

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Glucose Dependent Insulinotropic Receptor Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Glucose Dependent Insulinotropic Receptor Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Glucose Dependent Insulinotropic Receptor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Glucose Dependent Insulinotropic Receptor Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Glucose Dependent Insulinotropic Receptor Market Analysis and Outlook to 2022

    • 7.1 Global Glucose Dependent Insulinotropic Receptor Consumption (2017-2022)

    • 7.2 United States Glucose Dependent Insulinotropic Receptor Consumption (2017-2022)

    • 7.3 Europe Glucose Dependent Insulinotropic Receptor Consumption (2017-2022)

    • 7.4 China Glucose Dependent Insulinotropic Receptor Consumption (2017-2022)

    • 7.5 Japan Glucose Dependent Insulinotropic Receptor Consumption (2017-2022)

    • 7.6 India Glucose Dependent Insulinotropic Receptor Consumption (2017-2022)

    • 7.7 South Korea Glucose Dependent Insulinotropic Receptor Consumption (2017-2022)

    8 Region and Country-wise Glucose Dependent Insulinotropic Receptor Market Analysis and Outlook to 2028

    • 8.1 Global Glucose Dependent Insulinotropic Receptor Consumption Forecast (2022-2028)

    • 8.2 United States Glucose Dependent Insulinotropic Receptor Consumption Forecast (2022-2028)

    • 8.3 Europe Glucose Dependent Insulinotropic Receptor Consumption Forecast (2022-2028)

    • 8.4 China Glucose Dependent Insulinotropic Receptor Consumption Forecast (2022-2028)

    • 8.5 Japan Glucose Dependent Insulinotropic Receptor Consumption Forecast (2022-2028)

    • 8.6 India Glucose Dependent Insulinotropic Receptor Consumption Forecast (2022-2028)

    • 8.7 South Korea Glucose Dependent Insulinotropic Receptor Consumption Forecast (2022-2028)

    9 Global Glucose Dependent Insulinotropic Receptor Market Outlook by Types and Applications to 2022

    • 9.1 Global Glucose Dependent Insulinotropic Receptor Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global DA-1241 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global GSK-2041706 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global HD-0471042 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global HD-0471953 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global HOB-047 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global MBX-2982 Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Glucose Dependent Insulinotropic Receptor Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Obesity Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Chronic Obstructive Pulmonary Disease (COPD) Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Dyslipidemia Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Glucose Dependent Insulinotropic Receptor Market Outlook by Types and Applications to 2028

    • 10.1 Global Glucose Dependent Insulinotropic Receptor Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global DA-1241 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global GSK-2041706 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global HD-0471042 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global HD-0471953 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global HOB-047 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global MBX-2982 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Glucose Dependent Insulinotropic Receptor Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Obesity Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Chronic Obstructive Pulmonary Disease (COPD) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Dyslipidemia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Glucose Dependent Insulinotropic Receptor Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Glucose Dependent Insulinotropic Receptor Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Glucose Dependent Insulinotropic Receptor Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Glucose Dependent Insulinotropic Receptor Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Glucose Dependent Insulinotropic Receptor Market Competitive Analysis

    • 14.1 Dong-A Socio Holdings Co Ltd

      • 14.1.1 Dong-A Socio Holdings Co Ltd Company Details

      • 14.1.2 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.2 Novartis AG

      • 14.2.1 Novartis AG Company Details

      • 14.2.2 Novartis AG Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis AG Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.3 Amgen Inc

      • 14.3.1 Amgen Inc Company Details

      • 14.3.2 Amgen Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Amgen Inc Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.4 Hyundai Pharmaceutical Co Ltd

      • 14.4.1 Hyundai Pharmaceutical Co Ltd Company Details

      • 14.4.2 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.5 CymaBay Therapeutics Inc

      • 14.5.1 CymaBay Therapeutics Inc Company Details

      • 14.5.2 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.6 Takeda Pharmaceutical Co Ltd

      • 14.6.1 Takeda Pharmaceutical Co Ltd Company Details

      • 14.6.2 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.7 GlaxoSmithKline Plc

      • 14.7.1 GlaxoSmithKline Plc Company Details

      • 14.7.2 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.8 F Hoffmann-La Roche Ltd

      • 14.8.1 F Hoffmann-La Roche Ltd Company Details

      • 14.8.2 F Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 F Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.9 Merck & Co Inc

      • 14.9.1 Merck & Co Inc Company Details

      • 14.9.2 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.10 Kowa Co Ltd

      • 14.10.1 Kowa Co Ltd Company Details

      • 14.10.2 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.11 Yuhan Corp

      • 14.11.1 Yuhan Corp Company Details

      • 14.11.2 Yuhan Corp Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Yuhan Corp Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.12 Arena Pharmaceuticals Inc

      • 14.12.1 Arena Pharmaceuticals Inc Company Details

      • 14.12.2 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Product and Service

    • 14.13 Taisho Pharmaceutical Holdings Co Ltd

      • 14.13.1 Taisho Pharmaceutical Holdings Co Ltd Company Details

      • 14.13.2 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Glucose Dependent Insulinotropic Receptor

    • Figure Glucose Dependent Insulinotropic Receptor Picture

    • Table Global Glucose Dependent Insulinotropic Receptor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Glucose Dependent Insulinotropic Receptor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Glucose Dependent Insulinotropic Receptor Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Glucose Dependent Insulinotropic Receptor Consumption by Country (2017-2022)

    • Figure United States Glucose Dependent Insulinotropic Receptor Consumption and Growth Rate (2017-2022)

    • Table Europe Glucose Dependent Insulinotropic Receptor Consumption and Growth Rate (2017-2022)

    • Figure China Glucose Dependent Insulinotropic Receptor Consumption and Growth Rate (2017-2022)

    • Figure Japan Glucose Dependent Insulinotropic Receptor Consumption and Growth Rate (2017-2022)

    • Figure India Glucose Dependent Insulinotropic Receptor Consumption and Growth Rate (2017-2022)

    • Figure South Korea Glucose Dependent Insulinotropic Receptor Consumption and Growth Rate (2017-2022)

    • Figure Global Glucose Dependent Insulinotropic Receptor Consumption Forecast by Country (2022-2028)

    • Figure United States Glucose Dependent Insulinotropic Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Glucose Dependent Insulinotropic Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Glucose Dependent Insulinotropic Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Glucose Dependent Insulinotropic Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Glucose Dependent Insulinotropic Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Glucose Dependent Insulinotropic Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DA-1241 Consumption and Growth Rate (2017-2022)

    • Figure Global GSK-2041706 Consumption and Growth Rate (2017-2022)

    • Figure Global HD-0471042 Consumption and Growth Rate (2017-2022)

    • Figure Global HD-0471953 Consumption and Growth Rate (2017-2022)

    • Figure Global HOB-047 Consumption and Growth Rate (2017-2022)

    • Figure Global MBX-2982 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Obesity Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Obstructive Pulmonary Disease (COPD) Consumption and Growth Rate (2017-2022)

    • Figure Global Dyslipidemia Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global DA-1241 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global GSK-2041706 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HD-0471042 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HD-0471953 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HOB-047 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MBX-2982 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Obesity Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic Obstructive Pulmonary Disease (COPD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dyslipidemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Glucose Dependent Insulinotropic Receptor Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Glucose Dependent Insulinotropic Receptor Export by Region (Top 5 Countries) (2017-2028)

    • Table Dong-A Socio Holdings Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Glucose Dependent Insulinotropic Receptor Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Glucose Dependent Insulinotropic Receptor Product and Service

    • Table Hyundai Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product and Service

    • Table CymaBay Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Product and Service

    • Table Takeda Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Product and Service

    • Table Merck & Co Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Glucose Dependent Insulinotropic Receptor Product and Service

    • Table Kowa Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Product and Service

    • Table Yuhan Corp (Foundation Year, Company Profile and etc.)

    • Table Yuhan Corp Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yuhan Corp Glucose Dependent Insulinotropic Receptor Product and Service

    • Table Arena Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Product and Service

    • Table Taisho Pharmaceutical Holdings Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US